UPClytics
View all cases

UPC APP 546231/2023

Jul 11, 2023·EP3666797 · ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)

Case details
Status
Written Phase
Action
Generic
Category
File-access requests (R. 262.1(b))
Parties
Claimants
  • Name withheld (GDPR)
Representatives
  • Oswin Ridderbusch
Respondents
Representatives
Division
Munich CD
Technology
  • Chemistry
    Biotechnology · Pharmaceuticals
Language
English
EPO Opposition
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Munich CDLocked
Judge Ulrike VoßLocked
Judge András KupeczLocked
Judge Casper StruveLocked

At the UPC: Sanofi Group (33 cases)

Document titleDatePublic
Outcome of the Order2023-09-20Not public
Order rejecting Rule 262.1(b) application dated 20 September 20232023-09-20Not public
2023.08.30 ACT459505-2023 Sanofi - No comments on file inspection request (signed)2023-08-30Not public
2023.08.30 ACT459505-2023 Sanofi - No comments on file inspection request (signed)2023-08-30Not public
2023.08.30 ACT459505-2023 Sanofi - No comments on file inspection request (signed)2023-08-30Not public
Preliminary Order 262(1)(b) dated 28 August 20232023-08-28Not public
Comments in response to the Preliminary Order of August 4, 2023 submitted under Rule 264 RoP2023-08-18Not public
Preliminary Order 262(1)(b) dated 4 August 20232023-08-04Not public
Claimants' Reply to File Inspection Request2023-07-28Not public
Claimants' Reply to File Inspection Request2023-07-28Not public